STING Agonist Plays New Role in Head and Neck Cancer Therapy
The Yale Cancer Center has discovered a new role for Stimulator of Interferon Genes (STING) in head and neck cancer treatment. While STING.
Dentistry Today is The Nation’s Leading Clinical News Magazine for Dentists. Here you can get the latest dental news from the whole world quickly.
The Yale Cancer Center has discovered a new role for Stimulator of Interferon Genes (STING) in head and neck cancer treatment. While STING.
Researchers at the UCLA Jonsson Comprehensive Cancer Center and UCLA School of Dentistry have identified a potential new combination therapy to treat advanced.
The Oral Health Foundation is asking everyone to be “mouth aware” as it prepares for Mouth Cancer Action Month in November, with an.
As an oral and maxillofacial pathologist, I have the unique perspective of both seeing patients who are referred to me for assessment of.
Michael Daldry, a first-year dental student at the Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), will use a £1,000 ($1,249.70) award.
Michael Daldry, a first-year dental student at the Plymouth University Peninsula Schools of Medicine and Dentistry (PUPSMD), will use a £1,000 ($1,249.70) award.
Targeting cancer stem cells may be a more effective way to overcome cancer resistance and prevent the spread of squamous cell carcinoma, which.
A new immunotherapy drug known as nivolumab greatly improves survival for patients with relapsed head and neck cancer, as more than twice as.
It should have been a great day. Not only was Christmas just around the corner, but my best friend was my last hygiene.
Researchers at the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center have found that HPV-positive (human papillomavirus) patients with oropharyngeal cancer of.